Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Transfemoral aortic valve implantation: bleeding events, related costs and outcomes.

Reinöhl J, Gutmann A, Kollum M, von Zur Mühlen C, Baumbach H, Avlar M, Moser M, Bode C, Zehender M.

J Thromb Thrombolysis. 2013 May;35(4):469-75. doi: 10.1007/s11239-012-0829-0.

PMID:
23108526
2.

In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany.

Möllmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C.

Clin Res Cardiol. 2016 Jun;105(6):553-9. doi: 10.1007/s00392-016-0962-4. Epub 2016 Jan 30.

PMID:
26830097
3.

Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.

Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, Leshnower BG, Guyton RA, Kanitkar M, Keegan P, Simone A, Stewart JP, Ghasemzadeh N, Block P, Thourani VH.

JACC Cardiovasc Interv. 2014 Aug;7(8):898-904. doi: 10.1016/j.jcin.2014.04.005. Epub 2014 Jul 30.

4.

Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis.

Pilgrim T, Stortecky S, Luterbacher F, Windecker S, Wenaweser P.

J Thromb Thrombolysis. 2013 May;35(4):456-62. doi: 10.1007/s11239-012-0842-3.

PMID:
23143652
5.

Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.

Dahle G, Rein KA, Fiane A, Fosse E, Khushi I, Hagen T, Mishra V.

Scand Cardiovasc J. 2012 Dec;46(6):345-52. doi: 10.3109/14017431.2012.724177. Epub 2012 Oct 18.

PMID:
22917262
6.

Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.

Osten MD, Feindel C, Greutmann M, Chamberlain K, Meineri M, Rubin B, Mezody M, Ivanov J, Butany J, Horlick EM.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):475-85. doi: 10.1002/ccd.22291.

PMID:
19937781
7.

Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.

Arnold SV, Lei Y, Reynolds MR, Magnuson EA, Suri RM, Tuzcu EM, Petersen JL 2nd, Douglas PS, Svensson LG, Gada H, Thourani VH, Kodali SK, Mack MJ, Leon MB, Cohen DJ; PARTNER Investigators.

Circ Cardiovasc Interv. 2014 Dec;7(6):829-36. doi: 10.1161/CIRCINTERVENTIONS.114.001395. Epub 2014 Oct 21.

8.

Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.

Mwipatayi BP, Picardo A, Masilonyane-Jones TV, Larbalestier R, Thomas S, Turner J, Vijayan V, Yong G.

J Vasc Surg. 2013 Oct;58(4):1028-36.e1. doi: 10.1016/j.jvs.2013.03.046. Epub 2013 Aug 28.

9.

Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).

Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.

J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. doi: 10.1016/j.jacc.2013.10.058. Epub 2013 Nov 27.

10.

Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.

Borz B, Durand E, Godin M, Tron C, Canville A, Litzler PY, Bessou JP, Cribier A, Eltchaninoff H.

Heart. 2013 Jun;99(12):860-5. doi: 10.1136/heartjnl-2012-303095. Epub 2012 Dec 12.

PMID:
23236027
11.

[The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].

Bartoli S, Saia F, Marrozzini C, Berti E, Guastaroba P, Fortuna D, Ciuca C, Moretti C, Marzocchi A, De Palma R.

G Ital Cardiol (Rome). 2012 Jan;13(1):50-8. doi: 10.1714/1015.11056. Italian.

PMID:
22322472
12.

Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.

Genereux P, Kodali S, Leon MB, Smith CR, Ben-Gal Y, Kirtane AJ, Daneault B, Reiss GR, Moses JW, Williams MR.

JACC Cardiovasc Interv. 2011 Aug;4(8):861-7. doi: 10.1016/j.jcin.2011.05.019.

13.

Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.

Shah AM, Ogbara J, Herrmann HC, Fox Z, Kadakia M, Anwaruddin S, Bavaria JE, Desai ND, Jagasia D, Szeto WY, Li RH, Vallabhajosyula P, Giri J.

Catheter Cardiovasc Interv. 2015 Nov;86(5):888-94. doi: 10.1002/ccd.25994. Epub 2015 May 11.

PMID:
25963625
14.

In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions.

Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, van der Boon R, van Geuns RJ, van Domburg RT, Koudstaal PJ, Kappetein AP, Serruys PW, de Jaegere PP.

Catheter Cardiovasc Interv. 2011 Sep 1;78(3):457-67. doi: 10.1002/ccd.23018. Epub 2011 May 11.

PMID:
21563291
15.

Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.

Ciuca C, Tarantini G, Latib A, Gasparetto V, Savini C, Di Eusanio M, Napodano M, Maisano F, Gerosa G, Sticchi A, Marzocchi A, Alfieri O, Colombo A, Saia F.

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):332-8. doi: 10.1002/ccd.26012. Epub 2015 May 22.

PMID:
26010724
16.

Management of vascular complications following transcatheter aortic valve implantation.

Perrin N, Ellenberger C, Licker M, Hachulla AL, Cikirikcioglu M, Frei A, Roffi M, Noble S.

Arch Cardiovasc Dis. 2015 Oct;108(10):491-501. doi: 10.1016/j.acvd.2015.03.007.

17.

Transfemoral aortic valve implantation new criteria to predict vascular complications.

Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC.

JACC Cardiovasc Interv. 2011 Aug;4(8):851-8. doi: 10.1016/j.jcin.2011.03.019.

18.

Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.

Fink N, Segev A, Barbash I, Bogdan A, Hamdan A, Mazin I, Maor E, Hay I, Guetta V, Fefer P.

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):341-6. doi: 10.1002/ccd.26014. Epub 2015 May 23.

PMID:
26010839
19.

Colombian experience with transcatheter aortic valve implantation of medtronic CoreValve.

Dager AE, Nuis RJ, Caicedo B, Fonseca JA, Arana C, Cruz L, Benitez LM, Nader CA, Duenas E, de Marchena EJ, O'Neill WW, de Jaegere PP.

Tex Heart Inst J. 2012;39(3):351-8.

20.

Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.

Katz M, Carlos Bacelar Nunes Filho A, Caixeta A, Antonio Carvalho L, Sarmento-Leite R, Alves Lemos Neto P, Eduardo Koenig São Thiago L, Dias Dourado Oliveira A, Antonio Marino M, Tadeu Tumelero R, Antonio Perin M, Abizaid A, Tarasoutchi F, Sândoli de Brito F Jr; Brazilian TAVI Registry investigators.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):429-436. doi: 10.1002/ccd.26658. Epub 2016 Jul 29.

PMID:
27468953

Supplemental Content

Support Center